WWOX and osteosarcoma: We have recently shown that depletion of both Wwox and p53 (DKO) in osteoblast progenitors, using Osterix1-Cre, accelerates osteosarcoma (OS) development, resulting in more aggressive and chemotherapy-resistant OS than p53 knockout alone (SKO) [11].